Representing RDD Pharma in a merger with a Nasdaq traded company

Partners Ofer Ben-Yehuda, Amir Iliescu and Doron Mutai & associates Daniel Kariv, Ofer Filhaber and Roni Lifshitz represented RDD Pharma in a merger transaction of the Nasdaq traded company Innovate Biopharmaceuticals Inc.; the new name of the merged company is 9 Merers Biopharma Inc.

In addition, a third company was also acquired and 22M USD was raised in new financing that was led by Orbimed Advisors, LLC.

Read the full article

Related News

HIGH TECH

Representation of Aurora Labs in a US$ 23 million Series B financing round

Read More
HIGH TECH

Representation of Medasense Biometrics Ltd. in a US$ 18 million C round worth

Read More
Corporate

Representation of Knafei Nesharim Aviation in the acquisition of control of El Al

Read More
HIGH TECH

Representation of Tactile Mobility in a commercial cooperation agreement with BMW

Read More
Events

Open Source Webinar with The ACC, Adv. Ido Shomroni

Read More
HIGH TECH

The current funding atmosphere, Adv. Ofer Ben-Yehuda at ICSI

Read More